U.S. Court Formally Approves Imperial Tobacco Canada Restructuring Plan Involving US$23.6 Billion Settlement

Aug.28.2025
U.S. Court Formally Approves Imperial Tobacco Canada Restructuring Plan Involving US$23.6 Billion Settlement
The U.S. Bankruptcy Court in New York has approved and recognized the restructuring plan of Imperial Tobacco Canada Ltd., granting legal effect in the U.S. to its participation in a CA$32.5 billion (US$23.6 billion) tobacco litigation settlement. The case is considered one of the largest corporate restructurings in Canadian history and also involves Japan Tobacco International (JTI), Philip Morris International (PMI), and British American Tobacco (BAT).

Key Points

 

  • Court Ruling: U.S. Bankruptcy Court approved and recognized Imperial Tobacco Canada’s restructuring plan under Chapter 15 of the U.S. Bankruptcy Code.
  • Settlement Amount: The three tobacco companies will pay CA$32.5 billion (US$23.6 billion), including CA$12.5 billion (US$9.1 billion) in upfront cash, with the remainder from net after-tax income over the next 20 years.
  • Background: In 2019, Imperial Tobacco Canada, JTI-Macdonald, and Rothman Benson & Hedges faced claims totaling CA$1 trillion and entered insolvency proceedings.
  • International Dimension: While Imperial Tobacco Canada does not sell products overseas, its supply chain and inventory involve the U.S., along with legacy pension liabilities.

 


 

2Firsts, August 28, 2025 —— According to Law360 on August 26, U.S. Bankruptcy Judge John P. Mastando III of the Southern District of New York formally approved and recognized the restructuring plan of Imperial Tobacco Canada Ltd., thereby confirming the legal effect in the U.S. of its participation in the CA$32.5 billion (US$23.6 billion) tobacco litigation settlement.

 

The agreement is regarded as one of the largest restructurings in Canadian history. Imperial Tobacco Canada’s U.S. counsel, Jennifer Feldsher, stated in court: “This is one of the largest, if not the largest, restructurings in Canadian history.”

 

Imperial Tobacco Canada is one of the three largest tobacco distributors in Canada and a subsidiary of British American Tobacco (BAT). In 2019, the company, along with JTI-Macdonald Corp. and Rothman, Benson & Hedges Inc., entered Canadian insolvency proceedings in response to CA$1 trillion (US$725.6 billion) in health-related tobacco claims.

 

  • JTI-Macdonald Corp. is the Canadian subsidiary of Japan Tobacco International (JTI).
  • Rothmans, Benson & Hedges Inc. is the Canadian arm of Philip Morris International (PMI).
  • Imperial Tobacco Canada Ltd. is the Canadian subsidiary of British American Tobacco (BAT).

 

After years of mediation—delayed significantly by the COVID-19 pandemic—the parties reached a settlement in 2024. Under the terms, the three companies will pay into a CA$32.5 billion (US$23.6 billion) fund to compensate class action claimants and reimburse Canadian provincial governments for healthcare costs related to tobacco use.

 

The agreement stipulates that nearly CA$12.5 billion (US$9.1 billion) will be paid upfront in cash, while the remainder will be drawn from the majority of the companies’ net after-tax income over the next 20 years.

 

Feldsher noted that this settlement is the largest of its kind since the 1998 Master Settlement Agreement in the U.S., when American tobacco companies agreed to pay more than US$200 billion.

 

Imperial Tobacco Canada filed its restructuring plan in October 2024, which was approved by a Canadian court in March 2025. Although Imperial Tobacco Canada does not sell tobacco outside of Canada, its supply chain passes through the U.S., where it also stores inventory. The company also resolved legacy pension liabilities stemming from acquisitions of U.S. companies.

 

Subsequently, Imperial Tobacco Canada sought U.S. recognition of the plan. Judge Mastando granted the request, recognized the Canadian court-appointed plan administrator, and issued an order barring unauthorized solicitation of claims in the case.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore will maintain etomidate’s classification under drug control laws while preparing new legislation targeting e-vaporisers, as authorities reinforce a hardline regulatory stance on vaping.
Feb.05
Alcohol, tobacco and cannabis use among Spanish students aged 14–18 hits historic lows
Alcohol, tobacco and cannabis use among Spanish students aged 14–18 hits historic lows
Spain’s 2025 Survey on Drug Use in Secondary Education (ESTUDES), presented by the Ministry of Health, reports historic lows in alcohol, tobacco and cannabis consumption among students aged 14 to 18. The survey shows past-30-day drinking fell from 56.6% in 2023 to 51% in 2025, tobacco use from 21.0% to 15.5%, and cannabis use from 15.5% to 11.6%.
Feb.09 by 2FIRSTS.ai
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA has released the final batch of materials for ZYN MRTP applications and set March 4 (11:59 p.m. ET) as the deadline for public comments to be considered in the agency’s review.
Feb.03 by 2FIRSTS.ai
PMI launches IQOS Iluma i One in the UK, compatible with TEREA tobacco sticks
PMI launches IQOS Iluma i One in the UK, compatible with TEREA tobacco sticks
Philip Morris Limited (PML), the UK affiliate of Philip Morris International (PMI), has launched the latest addition to its heated tobacco IQOS lineup, the IQOS Iluma i One, in the UK. The device uses a bladeless induction-heating system and adds features such as a touchscreen and automatic start-up, while being designed for use with TEREA tobacco sticks, including the Pearls range.
Feb.10 by 2FIRSTS.ai
Product | 30ml E-Liquid, 40,000 Puffs, and Three Power Settings: OXBAR Launches New DTL Product ROVOTA
Product | 30ml E-Liquid, 40,000 Puffs, and Three Power Settings: OXBAR Launches New DTL Product ROVOTA
E-cigarette brand OXBAR has launched its new DTL e-cigarette, the OXBAR ROVOTA, on its official website. The product contains 30ml of e-liquid and is officially rated for up to approximately 40,000 puffs. It has a nicotine strength of 6mg and offers around 15 flavor options. The device is equipped with a 1400mAh battery, supports Type-C charging, features a 0.4Ω dual mesh coil, and supports three power settings of 20W, 30W, and 40W.
Mar.31 by 2FIRSTS.ai
Haypp confirms exit from UK vape category as it shifts focus to oral nicotine
Haypp confirms exit from UK vape category as it shifts focus to oral nicotine
Haypp, an online retailer of alternative nicotine products, has confirmed it is exiting the UK vape category as it shifts focus to the oral nicotine market. The company said analysis of its sales data showed increasing adoption of nicotine pouches across its six international markets: the UK, the USA, Germany, Norway, Switzerland and Sweden.
Mar.04 by 2FIRSTS.ai